CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) announced today that it had taken steps to improve its effectiveness in both its domestic and international operations. Effective immediately, Brian Lundstrom, who has been dividing his time between domestic operations and heading ISCO’s international partnering, has entered into a new contract with the Company that will allow him to focus exclusively on potential international partnering and therapeutic development programs in India, China, and elsewhere outside the U.S.
